The Gavi COVAX Advance Market Commitment Summit
2 June 2021 | 11:00 CEST
Watch the event recording above | View programme
World leaders unite to commit to global equitable access for COVID-19 vaccines
Global leaders and private sector companies have pledged US$ 2.4 billion to the COVAX Facility to accelerate access to 1.8 billion COVID-19 doses for lower-income economies. The pledges exceed the original US$ 2 billion target and bring the total raised to US$ 9.6 billion.
GAVI COVAX AMC DONORS
About
The Government of Japan will host the virtual Gavi COVAX Advance Market Commitment (AMC) Summit on 2 June 2021. The event will aim to accelerate access to 1.8 billion COVID-19 vaccine doses for lower-income economies via the Gavi COVAX Advance Market Commitment by raising an additional US$ 2 billion from donors and the private sector, in addition to US$ 6.3 billion already raised before the campaign was launched at the “One World Protected” event on 15 April 2021.
In addition to securing resources to accelerate global vaccination coverage, the Summit will bring together world leaders, the private sector, civil society and key technical partners to reflect on the challenges, successes and lessons learned; and look ahead to potential scenarios to address the pandemic and bolster global health security for the future.
Hosts
|
|
H.E. Suga Yoshihide |
|
|
|
José Manuel Barroso |
|
Japan support for Gavi
The Japanese government has supported Gavi since 2011, making a contribution of US$ 9 million every year until 2014.
In 2015, Japan doubled its contribution in support of health system recovery in the aftermath of the 2014 Ebola outbreaks. In May 2016. in the fringe of the G7 leaders’ Summit under its presidency, Japan for the first time announced a multi-year pledge to Gavi In 2019, Japan hosted the launch of Gavi’s third replenishment as part of TICAD 7 in Yokohama.
At the Global Vaccine Summit in June 2020, Japan announced to commit US$ 300 million to Gavi’s 2021-2025 vaccination programmes. As one of the first countries to join COVAX, Japan has already disbursed US$ 200 million to the Gavi COVAX AMC.
Timeline of Japanese support for Gavi
- 2011: Japan becomes a Gavi donor at the June 2011 pledging conference, committing US$ 9.3 million in direct contributions.
- 2015: Japan doubles its contribution in support of health system recovery after the 2014 Ebola outbreaks.
- 2016: Under its G7 presidency, Japan announces the first multi-year pledge to support Gavi’s 2016-2020 strategic period and provided a total of US$ 94.7 million.
- 2019: Japan hosts the launch meeting of Gavi’s third replenishment in Yokohama.
- 2020: Commitment of US$ 300 million to Gavi's 2021-2025 vaccination programmes.
- 2020: Japan becomes one of the first countries to join COVAX.
- 2021: Japan co-hosts with Gavi the virtual Gavi COVAX Advance Market Commitment (AMC) Summit.
The Gavi COVAX Advance Market Commitment (AMC) is an innovative financial mechanism that ensures the world’s poorest countries will get access to COVID-19 vaccines, regardless of their ability to pay.
Latest COVAX AMC news
We can stop the cycle of new variants continuing indefinitely with a pandemic vaccine pool
Without it we could face further delays in the global rollout and risk the gulf between the vaccine haves and have nots widening.
COVAX and the other international organizations committed to vaccine equity cannot end the COVID-19 pandemic without the continued support of governments, industry, and civil society. By working together, the world has a chance to tame the…
Vaccination started off slow, but has steadily increased over 2021 thanks to public health messaging and vaccine deliveries.
All around the world, COVAX deliveries are helping to protect frontline health workers, reach nomadic communities, reunite families and allow schools to reopen. Since deliveries began in March, #VaccinesWork has been publishing snapshots that…
How the public came together to support COVID-19 vaccines for the world’s most vulnerable
People around the world have demonstrated global solidarity by donating to the COVAX Facility, providing vaccines to those who would otherwise have no access.
Last updated: 19 Jan 2022